Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults : the IMCOVAS randomized clinical trial

Source
Vaccine - ISSN 0264-410X-42:25 (2024) p. 1-12
Author(s)